Jacob Forward ETF logo

Jacob Forward ETF (JFWD)

Market Closed
12 Jun, 20:00
ARCA ARCA
$
11. 88
-0.03
-0.2385%
$
2.4M Market Cap
- P/E Ratio
0.27% Div Yield
87 Volume
- Eps
$ 11.91
Previous Close
Add Transaction
Day Range
11.88 11.93
Year Range
9.02 13.56
Want to track JFWD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

JFWD closed Thursday lower at $11.88, a decrease of -0.2385% from Wednesday's close, completing a monthly increase of 0% or $11.88. Over the past 12 months, JFWD stock gained 0%.
JFWD pays dividends to its shareholders, with the most recent payment made on Dec 10, 2021. The next estimated payment will be in 10 Dec 2021 on Dec 10, 2021 for a total of $0.06716.
The stock of the company had never split.
The company's stock is traded on one exchange.

JFWD Chart

Jacob Forward ETF (JFWD) FAQ

What is the stock price today?

The current price is $11.88.

On which exchange is it traded?

Jacob Forward ETF is listed on ARCA.

What is its stock symbol?

The ticker symbol is JFWD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.27%.

What is its market cap?

As of today, the market cap is 2.4M.

Has Jacob Forward ETF ever had a stock split?

No, there has never been a stock split.

Jacob Forward ETF Profile

Capital Markets Industry
Financials Sector
- CEO
ARCA Exchange
469785703 CUSIP
US Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

The fund is managed with a focus on achieving its investment objective through a strategy centered around investing in a mix of common stocks and other equity securities across companies of various sizes. With an emphasis on building a portfolio predominantly comprised of common stocks, the fund also explores investments in other equity forms like preferred stocks, rights, or warrants. It showcases a notable inclination towards sectors such as health care and information technology, reflecting a strategic decision to leverage the growth potential and innovation within these industries. The investment approach is inclusive of a wide spectrum of companies, from well-established entities to those in the nascent stages of their development. Despite its broad investment horizon, the fund is characterized by a non-diversified status, implying a concentrated approach to its asset selection and portfolio construction.

Products and Services

  • Common Stocks

    The cornerstone of the fund's investment strategy, common stocks represent shares in the equity of companies across a diverse range of sizes. By investing in common stocks, the fund aims to capitalize on the growth potential and earnings dividends of its selected companies, while accepting the inherent market volatility and risks associated with equity investments.

  • Other Equity Securities

    Beyond common stocks, the fund broadens its investment landscape through engagements in preferred stocks, rights, and warrants. Preferred stocks offer a preferential claim over dividends and assets in case of liquidation, compared to common stocks, typically without voting rights. Rights and warrants are options that provide the holder the right to purchase company stock at a pre-determined price, potentially allowing the fund to invest at a favorable valuation.

  • Focus on Health Care and Information Technology Sectors

    In a strategic move to harness sector-specific growth and innovation, the fund exhibits significant exposure to the health care and information technology sectors. This exposure is predicated on the belief in the transformative potential and dynamism within these industries, seeking to reap benefits from advancements in medical technologies, pharmaceuticals, software, hardware, and services.

  • Investment in Early-Stage Companies

    A distinctive feature of the fund's approach is its inclusion of many companies that are in the early stages of their development. This investment thesis is grounded on the premise that early-stage companies, despite their higher risk profile due to unproven business models or market positions, present outsized growth opportunities compared to more established firms.

Contact Information

Address: -
Phone: -